Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology - PubMed (original) (raw)
Substance P and Human Immunodeficiency Virus Infection: Psychoneuroimmunology
Wen-Zhe Ho et al. CNS Spectr. 2002 Dec.
Abstract
Effects on the immune system caused by changes in behavioral state or brain activity are mediated, at least in part, through neuroendocrine-immune pathways. Life stress and depression may be associated with altered blood levels of central nervous system-released neuropeptides, including substance P (SP). SP acts as a neuroregulator or neurotransmitter in the conduction of nociceptive stimuli, and is a modulator of neuroimmunoregulation. This review summarizes current knowledge regarding the role of the neuropeptide, SP, in psychoneuroimmunology, in particular as it relates to human immunodeficiency virus infection and acquired immunodeficiency disease syndrome. The association between depression, anxiety, and stress in HIV-disease progression suggests that neurobiologic and neurophysiologic factors play a role in modulating HIV infection and responses to antiretroviral therapy. Individuals with HIV or AIDS may experience stressful life circumstances that can result in increased symptoms of anxiety, stress, and/or depression. Furthermore, psychological and psychiatric symptoms, which occur in individuals with HIV and AIDS, may be related to the progression of AIDS disease. This review presents evidence from the literature, as well as findings from basic investigations conducted in the authors' laboratories, demonstrating that SP may play an important role in HIV pathophysiology. SP can impact the susceptibility of immune cells to HIV infection and modulate immune cell functions in ways that may affect the course of HIV in infected individuals. Moreover, modulation of SP activity and SP receptor is being explored for its potential as a novel therapeutic approach to the treatment of some psychological and psychiatric disorders and to the design of new anti-HIV therapy.
Similar articles
- Substance P and neurokinin-1 receptor modulation of HIV.
Ho WZ, Douglas SD. Ho WZ, et al. J Neuroimmunol. 2004 Dec;157(1-2):48-55. doi: 10.1016/j.jneuroim.2004.08.022. J Neuroimmunol. 2004. PMID: 15579279 Review. - Psychoneuroimmunology and HIV infection.
Gorman JM, Kertzner R. Gorman JM, et al. J Neuropsychiatry Clin Neurosci. 1990 Summer;2(3):241-52. doi: 10.1176/jnp.2.3.241. J Neuropsychiatry Clin Neurosci. 1990. PMID: 2136081 Review. - Disturbed immunoregulatory properties of the neuropeptide substance P on lymphocyte proliferation in HIV infection.
Covas MJ, Pinto LA, Victorino RM. Covas MJ, et al. Clin Exp Immunol. 1994 Jun;96(3):384-8. doi: 10.1111/j.1365-2249.1994.tb06039.x. Clin Exp Immunol. 1994. PMID: 7516268 Free PMC article. - Insights into the Impact of CD8+ Immune Modulation on Human Immunodeficiency Virus Evolutionary Dynamics in Distinct Anatomical Compartments by Using Simian Immunodeficiency Virus-Infected Macaque Models of AIDS Progression.
Rife Magalis B, Nolan DJ, Autissier P, Burdo TH, Williams KC, Salemi M. Rife Magalis B, et al. J Virol. 2017 Nov 14;91(23):e01162-17. doi: 10.1128/JVI.01162-17. Print 2017 Dec 1. J Virol. 2017. PMID: 28931681 Free PMC article. - Substance P enhances HIV-1 replication in latently infected human immune cells.
Li Y, Douglas SD, Song L, Sun S, Ho WZ. Li Y, et al. J Neuroimmunol. 2001 Dec 3;121(1-2):67-75. doi: 10.1016/s0165-5728(01)00439-8. J Neuroimmunol. 2001. PMID: 11730941
Cited by
- Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
Chernova I, Lai JP, Li H, Schwartz L, Tuluc F, Korchak HM, Douglas SD, Kilpatrick LE. Chernova I, et al. J Leukoc Biol. 2009 Jan;85(1):154-64. doi: 10.1189/jlb.0408260. Epub 2008 Oct 3. J Leukoc Biol. 2009. PMID: 18835883 Free PMC article. - Detection of bacterial DNA in painful degenerated spinal discs in patients without signs of clinical infection.
Fritzell P, Bergström T, Welinder-Olsson C. Fritzell P, et al. Eur Spine J. 2004 Dec;13(8):702-6. doi: 10.1007/s00586-004-0719-z. Epub 2004 May 8. Eur Spine J. 2004. PMID: 15138861 Free PMC article. - Psychoneuroimmunoendocrinology: clinical implications.
González-Díaz SN, Arias-Cruz A, Elizondo-Villarreal B, Monge-Ortega OP. González-Díaz SN, et al. World Allergy Organ J. 2017 Jun 6;10(1):19. doi: 10.1186/s40413-017-0151-6. eCollection 2017. World Allergy Organ J. 2017. PMID: 28616124 Free PMC article. Review. - Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells.
Lu TS, Avraham HK, Seng S, Tachado SD, Koziel H, Makriyannis A, Avraham S. Lu TS, et al. J Immunol. 2008 Nov 1;181(9):6406-16. doi: 10.4049/jimmunol.181.9.6406. J Immunol. 2008. PMID: 18941231 Free PMC article. - Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.
Guo CJ, Douglas SD, Gao Z, Wolf BA, Grinspan J, Lai JP, Riedel E, Ho WZ. Guo CJ, et al. Glia. 2004 Nov 15;48(3):259-66. doi: 10.1002/glia.20079. Glia. 2004. PMID: 15390113 Free PMC article.